Reuters logo
BRIEF-Samsung Bioepis announced the European Commission’s approval of Imraldi
August 24, 2017 / 11:23 PM / a month ago

BRIEF-Samsung Bioepis announced the European Commission’s approval of Imraldi

Aug 24 (Reuters) - Samsung Bioepis Co Ltd

* Samsung Bioepis Co Ltd announced the European Commission’s approval of Imraldi, a biosimilar referencing Humira Source text for Eikon: [ID: nBw60ydvZa]

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below